EMEA-000876-PIP07-15
Key facts
| Invented name |
Soliris
|
| Active substance |
Eculizumab
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0229/2016
|
| PIP number |
EMEA-000876-PIP07-15
|
| Pharmaceutical form(s) |
Concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Prevention of delayed graft function after solid organ transplantation
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Alexion Europe SAS
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|